The efficacy of the long-acting neuroleptic oxyprothepin decanoate (HD), a new Czechoslovak drug, was evaluated in comparison with that of fluphenazine decanoate (FD). Within a year two groups consisting, respectively, of 19 and 17 patients were treated. The patients of the first group received FD for 6 months and then HD for the next 6 months. The patients of the second group received the same drugs, but in the reverse order (cross-testing). The degree of the psychic disturbances was assessed according to a special scale (Brief Psychiatric Rating Scale) with subsequent determination of the statistical significance of the differences revealed. As regards the efficacy HD appeared to be close to FD. No statistically significant differences between them were noted. The seeming superiority of HD over FD disappeared on introducing the correction for the order of their administration (the drug administered first produced a more marked therapeutic effect). Side effects due to both drugs were minor, however HD caused them in a far lesser number of patients than FD.

Download full-text PDF

Source

Publication Analysis

Top Keywords

fluphenazine decanoate
8
oxyprothepin decanoate
8
group received
8
[comparison effectiveness
4
effectiveness fluphenazine
4
decanoate
4
decanoate oxyprothepin
4
decanoate schizophrenia
4
schizophrenia double-blind
4
double-blind crossover
4

Similar Publications

Background: Fluphenazine decanoate licenced as a long-acting injectable (LAI) first-generation antipsychotic (FGA) was withdrawn from sale in 2018. This study evaluates if its withdrawal resulted in increased relapse rates of psychosis in an Irish patient cohort and examines which prescribed alternative antipsychotic medications were associated with more optimal outcomes.

Methods: Fifteen participants diagnosed with a psychotic disorder were included.

View Article and Find Full Text PDF

Racial and ethnic differences in patterns of use and discontinuation of long-acting injectable antipsychotics using Medicaid claims data.

Ment Health Clin

August 2023

Department Head and Kroger Professor, Department of Clinical and Administrative Pharmacy, College of Pharmacy, University of Georgia, Athens, Georgia.

Introduction: In general, racial and ethnic differences exist in antipsychotic prescription practices. However, little is known about such differences between individual long-acting injectable (LAI) antipsychotic formulations, specifically. This study's primary objective was to determine racial and ethnic differences among LAI antipsychotic use.

View Article and Find Full Text PDF

Nicolau syndrome is a rare condition characterized by severe pain at the site of injection, leading to ulceration and necrosis of the local tissues. Its presentation is usually acute. Nicolau syndrome is commonly seen in patients after intramuscular, intra-articular, or subcutaneous injections of non-steroidal anti-inflammatory drugs, antiepileptics, antipsychotics, antibiotics, antihistamines, and corticosteroids.

View Article and Find Full Text PDF

Schizophrenia is a severe chronic mental illness characterised by impaired emotional and cognitive functioning. To treat this condition, antipsychotics are available in limited dosage forms, mainly oral and injectable formulations. Although injectable antipsychotics were designed to enhance adherence, they are invasive, painful and require a healthcare professional to be administered.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!